Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lacer Oros is a comprehensive oral care product line developed by the Spanish pharmaceutical company Lacer. It is available in formulations such as toothpaste and mouthwash, specifically designed to address common dental issues including gingival inflammation (gingivitis), dental plaque, and dentin hypersensitivity. The formulation typically incorporates a combination of active ingredients: **sodium fluoride** for the remineralization of tooth enamel and prevention of dental caries; **potassium nitrate** to act as a desensitizing agent by reducing the excitability of dental nerves; and **zinc chloride** along with **o-cymen-5-ol** for their antibacterial and anti-plaque properties. Additionally, it contains **panthenol** (Pro-vitamin B5) and **dipotassium glycyrrhizate** to soothe, protect, and regenerate gingival tissues. Recent clinical evaluations, such as the trial NCT04881357, have specifically focused on the efficacy of the 'Acción Integral' (All-in-One) formula in patients undergoing supportive periodontal therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lacer Oros.